MDL IX definition

MDL IX means the MDL information exchange that receives and displays the tolerances, nominations, Scheduled Quantities, incentives and fees, certain notices and other information in relation to MDL’s operation of the open access regime for the Maui Pipeline and whose homepage is located at http.//www.mauipipeline.co.nz when accessed using the user name provided by MDL and the relevant password, or such other website as may be notified by MDL to each Shipper and Welded Party from time to time.
Sample 1Sample 2Sample 3

Examples of MDL IX in a sentence

  • Operating Code, of which the MDL IX is part, is substantially complete and ready for use.

  • The daily quantities of balancing gas purchased and sold by the Balancing Agent and the weighted average cost of the gas will be published on the MDL IX.

  • Once the GIC has approved the queuing rules, MDL will notify all Shippers of the amount of AQ available for allocation on the MDL IX and distribute AQ in accordance with such approved queuing rules.6.57.5 Subject to section 7.6, a Shipper will pay the AQ Fee in relation to every Day, regardless of that Shipper’s Approved Nominations for that Day.

  • It supports the following amendments: deletion of the references to the 'Industry Contingency Plan';increased information disclosure on the MDL IX; and the majority of the changes to the Prudential Requirements – sections 20.1, 20.2, 20.3(a), 20.6 and 20.7. However, Contact does not agree with the proposed changes to section 20.3(b) and 20.4(b), or the rationale MDL has given for them.

  • The April Change Request proposes changes that can be organised into three groups: Information on MDL IX (section 4);Prudential requirements (section 20); and Consequential changes and minor amendments.

  • The submissions made by Contact, EDNZ, MRP and Vector raise no objection to the proposed amendments in respect of the provision of information on MDL IX.

  • This document, and the other documents referred to above, can be viewed and downloaded from the Publications menu of the MDL IX under the heading “Critical Contingency”.

  • The Master Contracts are available on the MDL IX and proposals are being sought from the industry for the supply of Put Secondary Balancing Gas.

  • A review of the current tolerances on the Maui Pipeline and publication of a paper on the MDL IX setting out the findings on the appropriateness of the current tolerances.

  • The April Change Request proposes amendments to section 4 (MDL IX) of the MPOC.

Related to MDL IX

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • PTC means the tax credit for electricity produced from certain renewable generation resources described in Section 45 of the Internal Revenue Code of 1986, as it may be amended or supplemented from time to time.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • NPC means Nevada Power Company, a Nevada corporation. ---

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • ISIS means the department’s individualized services information system.

  • Pfizer means Pfizer Inc.

  • Collaborative agreement means a voluntary, written, or electronic arrangement between one

  • Detailed manufacturing or process data means technical data that describe the steps, sequences, and conditions of manufacturing, processing or assembly used by the manufacturer to produce an item or component or to perform a process.

  • Beam axis means a line from the source through the centers of the x-ray fields.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • CMC means Comprehensive maintenance Contract (labour, spare and preventive maintenance)

  • Amplification, transmission and distribution equipment means, but is not limited to, production,

  • Technology startup company means a for profit business that

  • Company License Agreements means any license agreements granting any right to use or practice any rights under any Intellectual Property (except for such agreements for off-the-shelf products that are generally available for less than $25,000), and any written settlements relating to any Intellectual Property, to which the Company is a party or otherwise bound; and the term “Software” means any and all computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code or object code.

  • GSK or ‘𝐺𝑆𝐾’ means the generation shift key as defined in Article 2(12) of the CACM Regulation;

  • After-Acquired Intellectual Property has the meaning assigned to such term in Section 4.02(d).

  • Company Licensed IP means all Intellectual Property rights owned or purported to be owned by a third party and licensed to the Company or any Company Subsidiary or that the Company or any Company Subsidiary otherwise has a right to use.

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • Collaborative matter means a dispute, transaction, claim, problem, or issue for resolution, including a dispute, claim, or issue in a proceeding, that is described in a collaborative law participation agreement and arises under the family or domestic relations law of this state, including any of the following:

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Collaborative law process means a procedure intended to resolve a collaborative matter without intervention by a tribunal in which persons sign a collaborative law participation agreement and are represented by collaborative lawyers.

  • End User License means any license terms imposed by any Third Party Vendor on Customers and End Users. “Force Majeure Event” means an event or occurrence:

  • Licensor Technology means the Licensor Patents and the Licensor Know-How.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.